dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multiple sklerose, schubförmig-remittierender - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
foster nexthaler 100 mikrogramm / 6 mikrogramm pro dosis pulver zur inhalation
chiesi gmbh (8051646) - beclometasondipropionat (ph.eur.); formoterolfumarat-dihydrat (ph.eur.) - pulver zur inhalation - teil 1 - pulver zur inhalation; beclometasondipropionat (ph.eur.) (04359) 100 mikrogramm; formoterolfumarat-dihydrat (ph.eur.) (23761) 6 mikrogramm
inuvair 200 mikrogramm/6 mikrogramm pro inhalation druckgasinhalation, lösung
chiesi gmbh (8051646) - beclometasondipropionat (ph.eur.); formoterolfumarat-dihydrat (ph.eur.) - druckgasinhalation, lösung - teil 1 - druckgasinhalation, lösung; beclometasondipropionat (ph.eur.) (04359) 200 mikrogramm; formoterolfumarat-dihydrat (ph.eur.) (23761) 6 mikrogramm
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
foster 100/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
chiesi pharmaceuticals gmbh - beclometasondipropionat; formoterolfumarat dihydrat - formoterol und andere m
formodual 100/6 mikrogramm/sprühstoß, druckgasinhalation, lösung
chiesi pharmaceuticals gmbh - beclometasondipropionat; formoterolfumarat dihydrat - formoterol und andere m
symbicort 80 µg/dose - 2,25 µg/dose druckgasinhalation, suspension
astrazeneca - budesonid; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 80 µg/dose - 2,25 µg/dose - budesonid 80 µg/dose; formoterolfumarat-dihydrat 2.25 µg/dosis - formoterol and budesonide